Stay updated on MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial
Sign up to get notified when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.

Latest updates to the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page
- Check2 days agoChange DetectedA new revision entry was added to the record history, updating the page from version v3.5.3 to v3.5.4. This reflects a minor update in the versioning of the page and does not alter displayed study data.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedA minor change updates the displayed ClinicalTrials.gov interface revision from v3.5.2 to v3.5.3, reflecting a site/version release rather than a change to the study record content.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision: v3.5.2 was added to the history and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry v3.5.0 was added and the previous v3.4.3 entry removed in the Record History. No substantive content changes are shown.SummaryDifference0.1%

- Check66 days agoChange DetectedA new Revision: v3.4.3 was added to the record history, and the previous Revision: v3.4.2 entry was removed.SummaryDifference0.1%

- Check94 days agoChange DetectedAdded Revision: v3.4.2; removed the previous funding/operating-status notice (Revision: v3.4.1).SummaryDifference0.7%

Stay in the know with updates to MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.